Literature DB >> 956874

Physiopathogenesis of subdural hematomas. Part 1: Histological and biochemical comparisons of subcutaneous hematoma in rats with subdural hematoma in man.

E L Labadie, D Glover.   

Abstract

The dorsal subcutaneous injection in rats of 12 ml or more of autologous hemolyzed whole blood clotted in situ induced the formation of sterile, hemispheric lesions, 47% of which showed an initial decrease in volume followed by a progressive enlargement. The behavior, histology, and biochemical characteristics of the liquid contents of these lesions were found to be remarkably similar to those of subdural hematomas in man. To evaluate the role of the various blood components that may have influenced the formation and growth of these lesions, more than 150 clots composed of human platelet-free plasma, autologous hemolyzed blood, or autologous whole blood were implanted subcutaneously in rats by either surgical or injection techniques. The in vitro behavior of the different clots used was also assessed. This systematic approach led to the following conclusions: 1) the composition and volumes of the clots are critical variables; 2) plasma-fibrin provides the matrix shape of the lesions; 3) the breakdown products derived from erythrocytes, hemoglobin, leukocytes, and other solid blood elements induce neomembrane formation and contribute to the lesion's subsequent growth; and 4) inflammation mechanisms appear to be essential, while cerebrospinal fluid plays no discernable role in this process.

Entities:  

Mesh:

Year:  1976        PMID: 956874     DOI: 10.3171/jns.1976.45.4.0382

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  32 in total

1.  Extrathoracic protrusion of a chronic expanding hematoma in the chest mimicking a soft tissue tumor.

Authors:  Makoto Takahama; Ryoji Yamamoto; Ryu Nakajima; Nobuhiro Izumi; Hirohito Tada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-04-18

2.  Expanding hematoma after extraperiosteal paraffin plombage.

Authors:  Hisaichi Tanaka; Akihide Matsumura; Keiji Iuchi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  Chronic expanding haematomas with interesting presentations.

Authors:  Vinayagam Lenin Babu; Manish M Rana; Buchi R B Arumilli; Tahmeena Dean; Charlotte Brown; A Paul
Journal:  Iowa Orthop J       Date:  2007

4.  Development of a tennis ball-sized tumor at the site of an implanted pacemaker.

Authors:  Masashi Okamoto; Takuji Yamada; Tomonori Amano; Shunzou Matsuoka; Hideki Hirai; Kazunori Masuda; Atsushi Sueyoshi
Journal:  J Cardiol Cases       Date:  2010-07-16

5.  Chronic expanding hematoma in the chest: A case report.

Authors:  Takafumi Sakuma; Norio Takayashiki; Kesato Iguchi; Katsunori Kagohashi; Hiroaki Satoh; Kensuke Nakazawa; Nobuyuki Hizawa
Journal:  Exp Ther Med       Date:  2018-04-24       Impact factor: 2.447

6.  Bizarre soft tissue tumour on the gluteus muscle: a case report of spontaneous chronic expanding haematoma.

Authors:  Yasuaki Tohma; Yoshio Mii; Yasuhito Tanaka
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-04-25

7.  Acute symptomatic hematoma with defined etiology seven years after breast reconstruction: A case report and literature review.

Authors:  Akhil K Seth; John Ys Kim
Journal:  Can J Plast Surg       Date:  2010

8.  A rare presentation of intrapericardial hematoma 20 months post aortic valve replacement.

Authors:  Khadhar Mohamed Sarjun Basha; Vijayanand Palanisamy; Ezhilan Janakiraman; Jacob Jamesraj; Sivakumar Pandian; Suresh Kumar Sangili; Mullasari Ajit Sankardas
Journal:  Indian Heart J       Date:  2015-04-27

9.  Platelet-activating factor (PAF) and the development of chronic subdural haematoma.

Authors:  Y Hirasima; S Endo; R Kato; T Ohmori; T Nagahori; M Nishijima; K Karasawa; S Nojima; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  Chronic expanding hematoma of the thorax.

Authors:  Yong Soo Kwon; Won-Jung Koh; Tae Sung Kim; Kyung Soo Lee; Byung-Tae Kim; Young Mok Shim
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.